Insider trading

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,041 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,041 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,041 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,041 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,041 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,041 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,041 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Sep 2026
Speiser Michael L Director · indirect
Sold on a plan
$297.25K 840 at 353.87
3.2%
Planned (10b5-1)
4 Sep 2026
Speiser Michael L Director · indirect
Sold on a plan
$297.25K 840 at 353.87
3.2%
Planned (10b5-1)
4 Sep 2026
Speiser Michael L Director · indirect
Sold on a plan
$297.25K 840 at 353.87
3.2%
Planned (10b5-1)
4 Sep 2026
Speiser Michael L Director · indirect
Sold on a plan
$297.25K 840 at 353.87
3.2%
Planned (10b5-1)
4 Sep 2026
Phipps Chad F See remarks below.
Sold at will
$295.05K 3,000 at 98.35
4.4%
Not planned
4 Sep 2026
ZEVNIK PAUL A Director · indirect
Sold at will
$293.97K 35,000 at 8.40
49.2%
Not planned
4 Sep 2026
Lipesky Scott D. EVP and COO
Sold at will
$293.64K 2,000 at 146.82
1.4%
Not planned
4 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer · indirect
Sold on a plan 2×
$278.25K 3,180 at 87.50
66.7%
Sold half or more
4 Sep 2026
HOU HONG Q President and CEO
Sold on a plan
$277.42K 2,000 at 138.71
3.2%
Planned (10b5-1)
4 Sep 2026
Dorfman Mark EVP, GC and Secretary
Sold on a plan
$276.50K 7,471 at 37.01
20.3%
Planned (10b5-1)
4 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$273.74K 38,500 at 7.11
0.9%
Not planned
4 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$273.74K 38,500 at 7.11
0.9%
Not planned
4 Sep 2026
Sold at will 15×
$262.76K 504 at 521.35
100%
Sold half or more
4 Sep 2026
Bernstein Harold President, R&D & CMO
Sold on a plan
$254.50K 9,705 at 26.22
100%
Sold half or more
4 Sep 2026
Sold at will
$252.89K 3,100 at 81.58
11.8%
Not planned
4 Sep 2026
BREWER BRADY ceo, International
Sold on a plan
$235.38K 2,229 at 105.60
3.0%
Planned (10b5-1)
4 Sep 2026
Budur Kumar CHIEF MEDICAL OFFICER
Sold at will
$230.91K 5,500 at 41.98
22.8%
Not planned
4 Sep 2026
Sold on a plan
$217.50K 1,500 at 145.00
17.4%
Planned (10b5-1)
4 Sep 2026
CHANG FRED FACHING Director · indirect
Sold at will
$212.10K 13,582 at 15.62
0.4%
Not planned
4 Sep 2026
Tregillis Cynthia L Chief Legal Officer & Corp Sec
Sold on a plan
$194.92K 432 at 451.20
0.4%
Planned (10b5-1)
4 Sep 2026
Cheng Marvin VP-Manufacturing, Secy
Sold at will
$193.50K 4,000 at 48.38
0.1%
Not planned
4 Sep 2026
Story Brooke Director
Sold at will
$187.27K 2,300 at 81.42
23.5%
Not planned
4 Sep 2026
Wang Yanjun CCO and GC · indirect
Sold on a plan 3×
$169.94K 1,500 at 113.29
11.9%
Planned (10b5-1)
4 Sep 2026
Islam Nayaab See Remarks
Sold at will
$164.18K 24,554 at 6.69
0.3%
Not planned
4 Sep 2026
Campbell Lisa M Director
Sold on a plan
$159.93K 4,598 at 34.78
19.1%
Planned (10b5-1)
4 Sep 2026
Chambers Rebecca Chief Financial Officer
Sold on a plan 2×
$157.39K 3,652 at 43.10
2.2%
Planned (10b5-1)
4 Sep 2026
Stahl Stephanie Director
Sold at will
$155.79K 1,185 at 131.47
22.5%
Not planned
4 Sep 2026
Corso Joseph John Chief Financial Officer
Sold on a plan
$146.21K 3,524 at 41.49
2.1%
Planned (10b5-1)
4 Sep 2026
Sold on a plan
$142.61K 403 at 353.87
1.8%
Planned (10b5-1)
4 Sep 2026
McGuire Annie EVP, General Counsel
Sold on a plan 2×
$140.21K 3,254 at 43.09
2.4%
Planned (10b5-1)
4 Sep 2026
Knutson Jeffrey Scott VP Finance, CFO, Secr & Trea
Sold at will
$137.22K 5,902 at 23.25
3.3%
Not planned
4 Sep 2026
Bitterman Kevin Director · indirect
Sold on a plan 3×
$135.05K 1,689 at 79.96
11.2%
Planned (10b5-1)
4 Sep 2026
Bennett Kelvin Eugene SVP Engineering
Sold at will
$132.89K 1,000 at 132.89
6.6%
Not planned
4 Sep 2026
COLLINS GARY S VICE CHAIRMAN · indirect
Sold at will
$128.53K 5,000 at 25.71
8.6%
Not planned
4 Sep 2026
Peters John Sheldon Chief Insurance Officer
Sold on a plan
$122.46K 2,249 at 54.45
3.0%
Planned (10b5-1)
4 Sep 2026
Allen Frances L. Director
Sold at will
$117.25K 500 at 234.50
3.8%
Not planned
4 Sep 2026
Sold on a plan
$108.75K 10,471 at 10.39
0.3%
Planned (10b5-1)
4 Sep 2026
Webb Mark W. EVP, CFO & COO
Sold on a plan
$102.48K 5,086 at 20.15
3.1%
Planned (10b5-1)
4 Sep 2026
Carlson Megan CAO and SVP, Finance
Sold at will
$100.80K 13,804 at 7.30
3.2%
Not planned
4 Sep 2026
Sudhir Srivastava Chairman and CEO · indirect
Sold at will
$100.00K 33,333 at 3.00
0.0%
Not planned
4 Sep 2026
Dolsten Mikael Director
Sold at will
$95.97K 634 at 151.38
11.4%
Not planned
4 Sep 2026
DILLON LARRY G EXECUTIVE CHAIRMAN
Sold at will
$95.07K 1,000 at 95.07
2.9%
Not planned
4 Sep 2026
Lee Gordon S CHIEF ACCOUNTING OFFICER
Sold on a plan
$91.48K 413 at 221.50
0.5%
Planned (10b5-1)
4 Sep 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$91.19K 3,745 at 24.35
2.2%
Planned (10b5-1)
4 Sep 2026
Mansharamani Leena SVP, Chief Accounting Officer
Sold on a plan 2×
$90.24K 2,706 at 33.35
4.8%
Planned (10b5-1)
4 Sep 2026
Sold on a plan
$89.44K 6,500 at 13.76
8.1%
Planned (10b5-1)
4 Sep 2026
Crone S Dustin PRESIDENT & CEO C&F FINANCE
Sold at will
$84.97K 900 at 94.41
9.7%
Not planned
4 Sep 2026
Wassil Jim EVP, Chief Scientific Ofc, COO
Sold at will
$84.46K 1,381 at 61.16
0.9%
Not planned
4 Sep 2026
Monnig Taylor CTO, COO
Sold on a plan
$56.90K 4,513 at 12.61
1.7%
Planned (10b5-1)
4 Sep 2026
RUHLMAN RANDALL M 10% owner
Sold at will
$56.81K 142 at 400.04
0.0%
Not planned
Showing 3,851–3,900 of 46,041. ← Newer Page 78 of 921 Older →